Skip to main content

Table 1 Effect of therapy on metastatic burden in mice bearing Pan02 tumors

From: The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer

GROUP

METASTASIS

 
 

Number

Incidence (%)

Control

14

6/8 (75)

CT

0

0/8 (0)

GEM

0

0/8 (0)

CT+ GEM

0

0/10 (0)

  1. Metastatic events in mice bearing orthotopic Pan02 tumors were evaluated by visual inspection of the liver, lungs, and entire gastrointestinal tract at the time of sacrifice.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us